RADIOPHARM THERANOSTICS LIMITED - Announcements

Market Cap $58.66M Add to my watchlist

Healthcare Biotechnology

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAD	RAD to present at JonesResearch Radiopharma Day		10:07	150.52KB	Share
RAD	Appointment of Noel Donnelly as Non-Executive Director		09:41	156.14KB	Share
RAD	ESG Report		30/09/24	419.98KB	Share
RAD	Corporate Governance Statement and Appendix 4G		30/09/24	467.09KB	Share
RAD	Annual Report		30/09/24	1.93MB	Share
RAD	RAD Launching American Depositary Receipt (ADR) Program		19/09/24	243.97KB	Share
RAD	Change of Director's Interest Notice (x6)		18/09/24	440.97KB	Share
RAD	Becoming a substantial holder (PH)		18/09/24	167.66KB	Share
RAD	Notification regarding unquoted securities - RAD		13/09/24	16.85KB	Share
RAD	Notice Under Section 708A		13/09/24	123.9KB	Share
RAD	Application for quotation of securities - RAD		13/09/24	18.9KB	Share
RAD	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/24	3.32MB	Share
RAD	Change in substantial holding		29/08/24	736.39KB	Share
RAD	Application for quotation of securities - RAD		29/08/24	16.87KB	Share
RAD	Placement Options Range of Units and Top 20 Holders		28/08/24	168.29KB	Share
RAD	Application for quotation of securities - RAD		28/08/24	19.75KB	Share
RAD	Ceasing to be a substantial holder		27/08/24	116.65KB	Share
RAD	Ceasing to be a substantial holder		27/08/24	251.03KB	Share
RAD	RAD increases ownership in Radiopharm Ventures to 75%	PRICE SENSITIVE	26/08/24	209.68KB	Share
RAD	Becoming a substantial holder		26/08/24	888.01KB	Share
RAD	Becoming a substantial holder		23/08/24	115.53KB	Share
RAD	Change in substantial holding		23/08/24	741.43KB	Share
RAD	Change in substantial holding		23/08/24	92.51KB	Share
RAD	Notice Under Section 708A		23/08/24	124.09KB	Share
RAD	Notification regarding unquoted securities - RAD		23/08/24	18.32KB	Share
RAD	Application for quotation of securities - RAD		23/08/24	16KB	Share
RAD	Notice Under Section 708A		21/08/24	124.03KB	Share
RAD	Application for quotation of securities - RAD		21/08/24	16.02KB	Share
RAD	Notice Under Section 708A		21/08/24	123.77KB	Share
RAD	Application for quotation of securities - RAD		21/08/24	16.02KB	Share
RAD	Dr Dimitris Voliotis appointed Chief Medical Officer		20/08/24	157.08KB	Share
RAD	A$70m capital raising & Lantheus investment approved at EGM		14/08/24	178.73KB	Share
RAD	Results of Extraordinary General Meeting		14/08/24	134.06KB	Share
RAD	Presentation to Extraordinary General Meeting		14/08/24	658.54KB	Share
RAD	Update - Proposed issue of securities - RAD		09/08/24	22.06KB	Share
RAD	Update - Proposed issue of securities - RAD		09/08/24	24.66KB	Share
RAD	Prospectus		09/08/24	1.28MB	Share
RAD	Radiopharm receives US$2.0 M payment from Lantheus		05/08/24	181.09KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	807.73KB	Share
RAD	Radiopharm targets Nasdaq Listing by end of 2024		26/07/24	162.75KB	Share
RAD	FDA IND approval for Phase 2b trial in brain metastases	PRICE SENSITIVE	23/07/24	156.63KB	Share
RAD	Correction to Notice of Extraordinary General Meeting		17/07/24	249.24KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		16/07/24	536.36KB	Share
RAD	First patient dosed in Phase 1 therapeutic lung cancer trial	PRICE SENSITIVE	10/07/24	204.12KB	Share
RAD	Ceasing to be a substantial holder		08/07/24	278.15KB	Share
RAD	Change in substantial holding PH		05/07/24	263.92KB	Share
RAD	Becoming a substantial holder		03/07/24	619.08KB	Share
RAD	Becoming a substantial holder		03/07/24	779.54KB	Share
RAD	GN20 Disclosure		03/07/24	597.33KB	Share
RAD	Notice Under Section 708A		02/07/24	124.15KB	Share
RAD	RAD notifies end of share agreements with Lind Partners		02/07/24	126.62KB	Share
RAD	Application for quotation of securities - RAD		01/07/24	15.71KB	Share
RAD	Investor webinar 3pm AEST Tuesday 2 July		27/06/24	152.2KB	Share
RAD	Reinstatement to Quotation	PRICE SENSITIVE	25/06/24	86KB	Share
RAD	Proposed issue of securities - RAD		25/06/24	21.97KB	Share
RAD	Proposed issue of securities - RAD		25/06/24	15.96KB	Share
RAD	Lantheus Strategic Investment and Capital Raise Presentation		25/06/24	3.28MB	Share
RAD	Radiopharm Theranostics completes A$70 million placement	PRICE SENSITIVE	25/06/24	229.95KB	Share
RAD	Suspension from Quotation	PRICE SENSITIVE	24/06/24	512.18KB	Share
RAD	Proposed issue of securities - RAD		20/06/24	24.53KB	Share
RAD	Radiopharm Receives Strategic Investment for up to A$18 mill	PRICE SENSITIVE	20/06/24	206.06KB	Share
RAD	Trading Halt	PRICE SENSITIVE	20/06/24	185.1KB	Share
RAD	Change in substantial holding NanoMab		23/05/24	748.95KB	Share
RAD	Change in substantial holding PH		23/05/24	264.07KB	Share
RAD	Notice Under Section 708A		16/05/24	124.05KB	Share
RAD	Application for quotation of securities - RAD		16/05/24	16.24KB	Share
RAD	RAD to be featured at B. Riley Securities Healthcare events		08/05/24	232.73KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	1.4MB	Share
RAD	Notification regarding unquoted securities - RAD		24/04/24	16.99KB	Share
RAD	Radiopharm Ventures institutional & VC presentation		22/04/24	2.42MB	Share
RAD	Notice Under Section 708A		15/04/24	123.71KB	Share
RAD	Application for quotation of securities - RAD		15/04/24	15.68KB	Share
RAD	Results of Extraordinary General Meeting		15/04/24	129.42KB	Share
RAD	Presentation to Extraordinary General Meeting		15/04/24	574.69KB	Share
RAD	Initial Director's Interest Notice PH		26/03/24	238.44KB	Share
RAD	Final Director's Interest Notice MB		26/03/24	264.37KB	Share
RAD	Board Changes		26/03/24	183.12KB	Share
RAD	RAD to present at NWR Virtual Healthcare Conference		19/03/24	204.51KB	Share
RAD	RAD 301 and 302 data shows value of targeting avb6-integrin		15/03/24	381.24KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		15/03/24	704.35KB	Share
RAD	Notice Under Section 708A		12/03/24	124.06KB	Share
RAD	Application for quotation of securities - RAD		12/03/24	15.85KB	Share
RAD	Multiple RAD301 data releases to be presented at EMIM		06/03/24	254.09KB	Share
RAD	Notice Under Section 708A		04/03/24	123.77KB	Share
RAD	Application for quotation of securities - RAD		04/03/24	16.03KB	Share
RAD	B Riley Securities Radiopharma Conference Presentation		04/03/24	1.16MB	Share
RAD	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	1.55MB	Share
RAD	Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301	PRICE SENSITIVE	29/02/24	288.52KB	Share
RAD	Pilot Study Validates RAD Terbium-161 Radiotherapeutics	PRICE SENSITIVE	28/02/24	265.19KB	Share
RAD	Participation in B. Riley Securities Radiopharma Conference		23/02/24	204KB	Share
RAD	Radiopharm receives $1.9 M advance on FY24 R&D tax incentive	PRICE SENSITIVE	21/02/24	147.07KB	Share
RAD	Notice Under Section 708A		14/02/24	123.9KB	Share
RAD	Application for quotation of securities - RAD		14/02/24	15.89KB	Share
RAD	Application for quotation of securities - RAD		09/02/24	15.96KB	Share
RAD	Update - Proposed issue of securities - RAD		06/02/24	15.75KB	Share
RAD	RAD Share Facility Agreement of up to A$12.5m addendum		06/02/24	312.65KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	17.07KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.34KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.47KB	Share
RAD	RAD secures Share Facility Agreement of up to A$12.5m	PRICE SENSITIVE	06/02/24	308.86KB	Share

RAD RAD to present at JonesResearch Radiopharma Day
10:07		150.52KB	Share
RAD Appointment of Noel Donnelly as Non-Executive Director
09:41		156.14KB	Share
RAD ESG Report
30/09/24		419.98KB	Share
RAD Corporate Governance Statement and Appendix 4G
30/09/24		467.09KB	Share
RAD Annual Report
30/09/24		1.93MB	Share
RAD RAD Launching American Depositary Receipt (ADR) Program
19/09/24		243.97KB	Share
RAD Change of Director's Interest Notice (x6)
18/09/24		440.97KB	Share
RAD Becoming a substantial holder (PH)
18/09/24		167.66KB	Share
RAD Notification regarding unquoted securities - RAD
13/09/24		16.85KB	Share
RAD Notice Under Section 708A
13/09/24		123.9KB	Share
RAD Application for quotation of securities - RAD
13/09/24		18.9KB	Share
RAD Appendix 4E and Preliminary Final Report
30/08/24	PRICE SENSITIVE	3.32MB	Share
RAD Change in substantial holding
29/08/24		736.39KB	Share
RAD Application for quotation of securities - RAD
29/08/24		16.87KB	Share
RAD Placement Options Range of Units and Top 20 Holders
28/08/24		168.29KB	Share
RAD Application for quotation of securities - RAD
28/08/24		19.75KB	Share
RAD Ceasing to be a substantial holder
27/08/24		116.65KB	Share
RAD Ceasing to be a substantial holder
27/08/24		251.03KB	Share
RAD RAD increases ownership in Radiopharm Ventures to 75%
26/08/24	PRICE SENSITIVE	209.68KB	Share
RAD Becoming a substantial holder
26/08/24		888.01KB	Share
RAD Becoming a substantial holder
23/08/24		115.53KB	Share
RAD Change in substantial holding
23/08/24		741.43KB	Share
RAD Change in substantial holding
23/08/24		92.51KB	Share
RAD Notice Under Section 708A
23/08/24		124.09KB	Share
RAD Notification regarding unquoted securities - RAD
23/08/24		18.32KB	Share
RAD Application for quotation of securities - RAD
23/08/24		16KB	Share
RAD Notice Under Section 708A
21/08/24		124.03KB	Share
RAD Application for quotation of securities - RAD
21/08/24		16.02KB	Share
RAD Notice Under Section 708A
21/08/24		123.77KB	Share
RAD Application for quotation of securities - RAD
21/08/24		16.02KB	Share
RAD Dr Dimitris Voliotis appointed Chief Medical Officer
20/08/24		157.08KB	Share
RAD A$70m capital raising & Lantheus investment approved at EGM
14/08/24		178.73KB	Share
RAD Results of Extraordinary General Meeting
14/08/24		134.06KB	Share
RAD Presentation to Extraordinary General Meeting
14/08/24		658.54KB	Share
RAD Update - Proposed issue of securities - RAD
09/08/24		22.06KB	Share
RAD Update - Proposed issue of securities - RAD
09/08/24		24.66KB	Share
RAD Prospectus
09/08/24		1.28MB	Share
RAD Radiopharm receives US$2.0 M payment from Lantheus
05/08/24		181.09KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	807.73KB	Share
RAD Radiopharm targets Nasdaq Listing by end of 2024
26/07/24		162.75KB	Share
RAD FDA IND approval for Phase 2b trial in brain metastases
23/07/24	PRICE SENSITIVE	156.63KB	Share
RAD Correction to Notice of Extraordinary General Meeting
17/07/24		249.24KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
16/07/24		536.36KB	Share
RAD First patient dosed in Phase 1 therapeutic lung cancer trial
10/07/24	PRICE SENSITIVE	204.12KB	Share
RAD Ceasing to be a substantial holder
08/07/24		278.15KB	Share
RAD Change in substantial holding PH
05/07/24		263.92KB	Share
RAD Becoming a substantial holder
03/07/24		619.08KB	Share
RAD Becoming a substantial holder
03/07/24		779.54KB	Share
RAD GN20 Disclosure
03/07/24		597.33KB	Share
RAD Notice Under Section 708A
02/07/24		124.15KB	Share
RAD RAD notifies end of share agreements with Lind Partners
02/07/24		126.62KB	Share
RAD Application for quotation of securities - RAD
01/07/24		15.71KB	Share
RAD Investor webinar 3pm AEST Tuesday 2 July
27/06/24		152.2KB	Share
RAD Reinstatement to Quotation
25/06/24	PRICE SENSITIVE	86KB	Share
RAD Proposed issue of securities - RAD
25/06/24		21.97KB	Share
RAD Proposed issue of securities - RAD
25/06/24		15.96KB	Share
RAD Lantheus Strategic Investment and Capital Raise Presentation
25/06/24		3.28MB	Share
RAD Radiopharm Theranostics completes A$70 million placement
25/06/24	PRICE SENSITIVE	229.95KB	Share
RAD Suspension from Quotation
24/06/24	PRICE SENSITIVE	512.18KB	Share
RAD Proposed issue of securities - RAD
20/06/24		24.53KB	Share
RAD Radiopharm Receives Strategic Investment for up to A$18 mill
20/06/24	PRICE SENSITIVE	206.06KB	Share
RAD Trading Halt
20/06/24	PRICE SENSITIVE	185.1KB	Share
RAD Change in substantial holding NanoMab
23/05/24		748.95KB	Share
RAD Change in substantial holding PH
23/05/24		264.07KB	Share
RAD Notice Under Section 708A
16/05/24		124.05KB	Share
RAD Application for quotation of securities - RAD
16/05/24		16.24KB	Share
RAD RAD to be featured at B. Riley Securities Healthcare events
08/05/24		232.73KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	1.4MB	Share
RAD Notification regarding unquoted securities - RAD
24/04/24		16.99KB	Share
RAD Radiopharm Ventures institutional & VC presentation
22/04/24		2.42MB	Share
RAD Notice Under Section 708A
15/04/24		123.71KB	Share
RAD Application for quotation of securities - RAD
15/04/24		15.68KB	Share
RAD Results of Extraordinary General Meeting
15/04/24		129.42KB	Share
RAD Presentation to Extraordinary General Meeting
15/04/24		574.69KB	Share
RAD Initial Director's Interest Notice PH
26/03/24		238.44KB	Share
RAD Final Director's Interest Notice MB
26/03/24		264.37KB	Share
RAD Board Changes
26/03/24		183.12KB	Share
RAD RAD to present at NWR Virtual Healthcare Conference
19/03/24		204.51KB	Share
RAD RAD 301 and 302 data shows value of targeting avb6-integrin
15/03/24		381.24KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
15/03/24		704.35KB	Share
RAD Notice Under Section 708A
12/03/24		124.06KB	Share
RAD Application for quotation of securities - RAD
12/03/24		15.85KB	Share
RAD Multiple RAD301 data releases to be presented at EMIM
06/03/24		254.09KB	Share
RAD Notice Under Section 708A
04/03/24		123.77KB	Share
RAD Application for quotation of securities - RAD
04/03/24		16.03KB	Share
RAD B Riley Securities Radiopharma Conference Presentation
04/03/24		1.16MB	Share
RAD Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	1.55MB	Share
RAD Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301
29/02/24	PRICE SENSITIVE	288.52KB	Share
RAD Pilot Study Validates RAD Terbium-161 Radiotherapeutics
28/02/24	PRICE SENSITIVE	265.19KB	Share
RAD Participation in B. Riley Securities Radiopharma Conference
23/02/24		204KB	Share
RAD Radiopharm receives $1.9 M advance on FY24 R&D tax incentive
21/02/24	PRICE SENSITIVE	147.07KB	Share
RAD Notice Under Section 708A
14/02/24		123.9KB	Share
RAD Application for quotation of securities - RAD
14/02/24		15.89KB	Share
RAD Application for quotation of securities - RAD
09/02/24		15.96KB	Share
RAD Update - Proposed issue of securities - RAD
06/02/24		15.75KB	Share
RAD RAD Share Facility Agreement of up to A$12.5m addendum
06/02/24		312.65KB	Share
RAD Proposed issue of securities - RAD
06/02/24		17.07KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.34KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.47KB	Share
RAD RAD secures Share Facility Agreement of up to A$12.5m
06/02/24	PRICE SENSITIVE	308.86KB	Share

REFRESH

1 2 3

(20min delay)
Last 2.7¢		Change -0.001(3.57%)		Mkt cap ! $58.66M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.7¢	$63.33K	2.295M

Buyers (Bids)

No.	Vol.	Price($)
16	2706063	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	1451469	8

View Market Depth

No.	Vol.	Price($)
16	2713089	0.027
8	595813	0.026
4	806664	0.025
3	146664	0.024
2	130075	0.023

Price($)	Vol.	No.
0.028	1451469	8
0.029	336664	2
0.030	236664	3
0.031	826340	4
0.032	400000	1

Last trade - 14.54pm 02/10/2024 (20 minute delay)


Last 2.8¢		Change -0.001 ( 0.00 %)
Open	High	Low	Volume
2.9¢	2.9¢	2.7¢	692377
Last updated 14.02pm 02/10/2024 ?

RAD (ASX) Chart

RADIOPHARM THERANOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available